Cartesian Therapeutics Statistics
Total Valuation
RNAC has a market cap or net worth of $307.08 million. The enterprise value is $157.51 million.
Important Dates
The last earnings date was Thursday, August 7, 2025, before market open.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
RNAC has 26.00 million shares outstanding. The number of shares has increased by 203.30% in one year.
| Current Share Class | 26.00M |
| Shares Outstanding | 26.00M |
| Shares Change (YoY) | +203.30% |
| Shares Change (QoQ) | +2.10% |
| Owned by Insiders (%) | 58.38% |
| Owned by Institutions (%) | 26.20% |
| Float | 9.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 282.06 |
| Forward PS | 130.02 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 153.52 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.33
| Current Ratio | 13.33 |
| Quick Ratio | 13.11 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -13.65% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -21.35% |
| Revenue Per Employee | $15,545 |
| Profits Per Employee | -$549,394 |
| Employee Count | 66 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, RNAC has paid $287,000 in taxes.
| Income Tax | 287,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.01% in the last 52 weeks. The beta is 0.83, so RNAC's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | -7.01% |
| 50-Day Moving Average | 11.53 |
| 200-Day Moving Average | 15.19 |
| Relative Strength Index (RSI) | 48.33 |
| Average Volume (20 Days) | 55,567 |
Short Selling Information
The latest short interest is 2.44 million, so 9.39% of the outstanding shares have been sold short.
| Short Interest | 2.44M |
| Short Previous Month | 2.60M |
| Short % of Shares Out | 9.39% |
| Short % of Float | 26.01% |
| Short Ratio (days to cover) | 34.29 |
Income Statement
In the last 12 months, RNAC had revenue of $1.03 million and -$36.26 million in losses. Loss per share was -$1.49.
| Revenue | 1.03M |
| Gross Profit | -45.48M |
| Operating Income | -80.43M |
| Pretax Income | -248.65M |
| Net Income | -36.26M |
| EBITDA | -77.91M |
| EBIT | -80.43M |
| Loss Per Share | -$1.49 |
Full Income StatementBalance Sheet
The company has $160.32 million in cash and $13.35 million in debt, giving a net cash position of $146.98 million or $5.65 per share.
| Cash & Cash Equivalents | 160.32M |
| Total Debt | 13.35M |
| Net Cash | 146.98M |
| Net Cash Per Share | $5.65 |
| Equity (Book Value) | -2.53M |
| Book Value Per Share | -0.10 |
| Working Capital | 151.14M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$33.94 million and capital expenditures -$10.57 million, giving a free cash flow of -$44.51 million.
| Operating Cash Flow | -33.94M |
| Capital Expenditures | -10.57M |
| Free Cash Flow | -44.51M |
| FCF Per Share | -$1.71 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -7,838.89% |
| Pretax Margin | -3,506.14% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
RNAC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -203.30% |
| Shareholder Yield | -203.30% |
| Earnings Yield | -11.91% |
| FCF Yield | -14.62% |
Analyst Forecast
The average price target for RNAC is $40.00, which is 238.70% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $40.00 |
| Price Target Difference | 238.70% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 44.27% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 5, 2024. It was a reverse split with a ratio of 1:30.
| Last Split Date | Apr 5, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
RNAC has an Altman Z-Score of -2.12 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.12 |
| Piotroski F-Score | 2 |